Effects of Ruscogenin on Inflammation of Monocrotaline-Induced Pulmonary Artery Hypertension in Rats

Wei Xie

2013-01-01

Abstract:Aim To investigate the effects of ruscogenin on the inflammation of MCT-induced pulmonary artery hypertension(PAH)in rats.Methods Thirty-six SD rats were randomly divided into 3 groups(control group,MCT group and RUS group,n=12 for each group).MCT group and RUS group were injected intraperitoneally with monocrotaline 60 mg·kg-1.RUS group was treated with ruscogenin 0.4 mg·kg-1 from day 1 to day 21.The control group and MCT group were treated with the vehicle.On day 22,the mean pulmonary arterial pressure(mPAP) was measured and the small pulmonary arterial morphologic changes were detected by hematoxylin-eosin staining.Enzyme-linked immunosorbent assay(ELISA) was performed to analyze the content of interleukin-1β in peripheral blood and lung tissue.Immunohistochemisty for ED1+ monocytes was performed to detect the monocytes around pulmonary arteries.Results Ruscogenin significantly inhibited mPAP-increasing,small pulmonary artery wall thickening and monocytes infiltrating around pulmonary arteries induced by MCT.Moreover,ruscogenin prevented IL-1β increasing induced by MCT in both peripheral blood and lung tissue.Conclusions Ruscogenin can alleviate the pulmonary vascular inflammation,lower the mPAP,antagonize the pulmonary aterial wall thickness.It is a promising candidate for the treatment of pulmonary artery hypertension.